Completed NA INTERVENTIONAL 2-arm NCT02174666

Isoflavone Treatment for Postmenopausal Osteopenia.

The Effects of Red Clover Treatment on Bone Tissue Regulation in Postmenopausal Osteopenia.

Sponsor: European Regional Development Fund

Interventions Red clover extract Supplementation (placebo)

Updated 7 times since 2017 Last updated: Dec 1, 2023 Started: Jun 30, 2014 Primary completion: Oct 31, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02174666, this NA trial focuses on Osteopenia and Osteoporosis and remains completed. Sponsored by European Regional Development Fund, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2024 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Jan 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Regional Development Fund
The Ministry of Science, Technology and Innovation, Denmark
University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark